background image

Paid Clinical Trials Saint Paul

Discover 1,053 paid clinical trials in Saint Paul, Minnesota. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2
Active & Responsive

A Study of ASP1002 in Adults for Treatment of Solid Tumors

for
Advanced Solid Tumors
Location: 12 recruiting locations
Sponsor: Astellas Pharma Global Development, Inc.

Sex: All

Age: 18+

Code: NCT05719558

Phase1, Recruiting
Active & Responsive

The FLOTILLA Study: Providing Continued Access to The Study Medicines Encorafenib and Binimetinib for Participants in Prior Clinical Trials

for
Solid Tumors
Location: 9 recruiting locations
Sponsor: Pfizer

Sex: All

Age: 18+

Code: NCT05203172

Recruiting
Active & Responsive

Novel Post-Surgical Incision Management to Prevent Ostomy Complications

for
Ostomy, Enterocutaneous Fistula
Location: 1 recruiting location
Sponsor: HealthPartners Institute

Sex: All

Age: 18+

Code: NCT06524401

Recruiting
Active & Responsive

Study of INBRX-106 and INBRX-106 in Combination With Pembrolizumab (Keytruda®) in Subjects With Locally Advanced or Metastatic Solid Tumors (Hexavalent OX40 Agonist)

for
Solid Tumor, Non-Small Cell Lung Cancer, Head and Neck Cancer,
Location: 25 recruiting locations
Sponsor: Inhibrx Biosciences, Inc

Sex: All

Age: 18+

Code: NCT04198766

Phase1, Phase2, Recruiting
Active & Responsive

A Study of HC-7366 in Combination With Belzutifan (WELIREG™) in Patients With Renal Cell Carcinoma

for
Renal Cell Carcinoma
Location: 14 recruiting locations
Sponsor: HiberCell, Inc.

Sex: All

Age: 18+

Code: NCT06234605

Phase1, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image
Active & Responsive

Testing the Use of the Combination of Selumetinib and Olaparib or Selumetinib Alone Targeted Treatment for RAS Pathway Mutant Recurrent or Persistent Ovarian and Endometrial Cancers, A ComboMATCH Treatment Trial

for
Recurrent Endometrial Carcinoma,
Location: 219 recruiting locations
Sponsor: National Cancer Institute (NCI)

Sex: Female

Age: 18+

Code: NCT05554328

Phase2, Recruiting
Active & Responsive

Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET Imaging

for
Biochemically Recurrent Prostate Carcinoma,
Location: 194 recruiting locations
Sponsor: ECOG-ACRIN Cancer Research Group

Sex: Male

Age: 18+

Code: NCT04423211

Phase3, Recruiting
Active & Responsive

A Study of Tucatinib With Trastuzumab and mFOLFOX6 Versus Standard of Care Treatment in First-line HER2+ Metastatic Colorectal Cancer

for
Colorectal Neoplasms
Location: 63 recruiting locations
Sponsor: Seagen, a wholly owned subsidiary of Pfizer

Sex: All

Age: 18+

Code: NCT05253651

Phase3, Recruiting
Active & Responsive

Tirzepatide in PWS, HO and GNSO

for
Prader-Willi Syndrome, Hypothalamic Obesity, Obesity/Therapy
Location: 3 recruiting locations
Sponsor: Grace Kim

Sex: All

Age: 18 - 26

Code: NCT06901245

Recruiting
Active & Responsive

Prevalence of Antibodies and Cytokines in Participants With Chronic Granulomatous Disease

for
Chronic Granulomatous Disease (CGD)
Location: 50 recruiting locations
Sponsor: Ensoma

Sex: All

Age: 0+

Code: NCT06605378

Recruiting